China Association for Promotion of Health Science and Technology (CHSTPA) is a national, non-profit umbrella organization mainly aimed to promote the art and science of medicine and to improve the betterment of public health
The CHSTPA’s system of governance and policy making include the House of Delegates, the Board of Directors , the Supervisory Committees and CHSTPA senior leadership and staff
Better Health for Better Lives
To promote the development of science and technology for human health
To achieve its mission,CHSTPA has a wide range of activities.
All CHSTPA activities are aligned with the United Nations Sustainable Development Goals (SDGs), notably SDG 3 (Good health and well-being).
Promoting the integration of basic, clinical and scientific research
New technologies lead to innovation
Comprehensive, scientifically standardised and efficiently operated systems
Health management of the whole life cycle of the human body
The 6th Executive Committee 2024 - 2029 The activities of CHSTPA are managed by the Board of Directors, which consists of eight members.
President
Dr. ZHU Jun
Professor
Department of Internal Medicine
Peking University Cancer Hospital
Secretory General
Dr. XIA Cencan
Professor
Vice President
Dr. LUAN Jie
Professor
Breast Plastic Surgery Center
Plastic Surgery Hospital (Institute),CAMS,PUMC
Vice President
Mr. JIN Changxiao
Researcher
Peking University Third Hospital
Vice President
Dr. ZHANG Haicheng
Professor
Department of Cardiology
Peking University People's Hospital
Vice President
Dr. ZHU Lan
Professor
Department of Obstetrics and Gynecology
Peking Union Medical College Hospital
Vice President
Dr. LIU Lianxin
Professor
Department of Hepatobiliary Surgery
The First Affilated Hospital of USTC
Vice President
Dr. XUE Wujun
Professor
Department of Renal Transplantation
The First Affilated Hospital of Xi'an Jiao Tong University
The 6th Executive Committee 2024 - 2029 Supervisory Board of the Association 2024-2029
Chairman
Dr. LIU Peng
Professor
Director of Vascular Surgery
China Japan Friendship Hospital
Deputy Chairman
Mr. WU Changxia
Chairman
Peking University Yanyuan Investment Group
Supervisor
Mr. HE Guoke
Professor
Lawyer
Employee supervisor
Mrs. ZHAO Duan
Deputy Director of the Secretariat
CHSTPA was established in Beijing on September 1st 1992 as an association registered with the Ministry of Civil Affairs of the People's Republic of China
Li Zhensheng, the academician of China Scientific Academy, former vice-president of the Chinese Academy of Sciences and vice-chairman of Chinese Association for Science and Technology, was the first president of CHSTPA.
With health as the cornerstone, science and technology as the guide, and by means of high and new technology, we aim to organize and unite the general medical, health care and related scientific and technical workers, attract both domestic and abroad forces to organically combine human information big data, medical artificial intelligence, life science with health care, frontier interdisciplinary research, and transformation of scientific research achievements. To promote the development of science and technology for human health, we will make positive contributions to the implementation of the Healthy China strategy. We seek to accomplish the following aims:
Discover, recommend and cultivate outstanding scientific and technological talents and management talents in the field of medical and health care and big health, carry out publicity, education, medical science and technology training and other related activities; carry out public welfare activities such as public health clinics, relief of serious illnesses, training of medical talents, etc., and promote the revitalisation of the countryside to assist in the strategy of Healthy China;
To carry out human health, medical science and technology recommendation and coordination work, clinical new technology demonstration work, put forward medicine and health, health science and technology policy recommendations; authorised by the relevant government departments, to carry out medicine and health science and technology market research, industry assessment and consulting services for the development of the industry to provide references.
The CHSTPA Speciality Committees is a body specialising in a specific scope of human medicine, health, medical science and technology in accordance with the business scope of the CHSTPA.
The CHSTPA Speciality Committees consist of renowned experts who are interest-based groups that offer members the opportunity to promote excellence in the practice of diagnosis and treatment of focused diseases by various academic exchange activities, to increase relevant knowledge and skills, and interact with peers with similar interests or backgrounds.
The Medical Tissue Bank (Biospecimen Bank) and Research Centre of the CHSTPA is an open research platform for CHSTPA to provide its members with scientific research and scientific and technological achievements. At present, the Centre has established experimental technology platforms for molecular biology, cell biology, bioinformatics, reproductive genetics, experimental animals, etc., and is equipped with large-scale equipment platforms for single-cell sequencing, single-cell immunomics, body fluid proteomics, spatial transcriptomics, spatial metabolomics, etc., to meet the needs for preservation of medical tissues and biospecimens, basic and clinical research on stem cells, immune cells, gene therapy, etc., and clinical translation of medical devices and new drugs in the biomedical field. It can meet the needs of basic and clinical research on medical tissue and biological samples, stem cells, immune cells, gene therapy and other technologies, as well as the needs of clinical transformation of medical devices and new drugs in the field of biomedicine. It provides comprehensive services and strong support for scientific research and transformation of scientific and technological achievements.
The Centre has 23 full-time researchers, including 4 PhDs, 14 masters and 5 undergraduates. The research team of the Centre focuses on multi-omics integration and analysis, such as single-cell transcriptomics, single-cell epigenomics, proteomics, spatial transcriptomics, spatial metabolomics technology and data integration and analysis, and can work with members to carry out basic research in biomedicine-related fields and clinical research project design, experimental operation, data analysis, system construction and other work.
The centre has established several experimental platforms for molecular biology, cell biology, bioinformatics, biochemistry, immunology, etc. In addition to protein blotting (Western blot-WB), enzyme immunoassay (Elisa), real-time quantitative PCR, apoptosis assay (TUNEL), in-situ hybridisation (ISH), fluorescence in-situ hybridisation (FISH), In addition to conventional cell biology and molecular biology experiments such as pathological morphology staining and tissue microarrays, immunohistochemistry experiments, immunohistochemistry multiple staining (mIHC) cell immunofluorescence experiments, flow cytometric analyses, etc., we can also carry out the research and development of medical tissue/cells preservation, medical tissue engineering materials, gene editing (CRISPR-Cas9, in vitro transcription of mRNA), stem cell and immune cell basic and clinical research (mesenchymal and interstitial). Basic and clinical research on stem cells and immune cells (MSCs, iPSCs, DCs, NKs, organoids, embryos/chimeras), cellular phenotyping and functional analysis (mitochondrial energy metabolism, small animal in vivo imaging, real-time cytotoxicity experiments), bioinformatics (tumour neoantigen analysis, machine learning/image recognition), and the construction of animal models, as well as other experiments and related clinical research.
For general matters Secretory Office: Bangongshi@chstpa.com
For International Cooperation International Cooperation Department: xs.zhang@chstpa.com